Lords Chloro Alkali Surges on Stellar Q3 Results, Rs 42.7 Cr Warrant Conversion

CHEMICALS
Whalesbook Logo
AuthorVihaan Mehta|Published at:
Lords Chloro Alkali Surges on Stellar Q3 Results, Rs 42.7 Cr Warrant Conversion
Overview

Lords Chloro Alkali Limited posted robust Q3 FY25 results, with revenue climbing 45.6% YoY to ₹939.52 Cr and PAT surging 262.2% YoY to ₹4.61 Cr. For the nine-month period, revenue grew 53.6% to ₹2,924.94 Cr and PAT increased 572.9% to ₹24.10 Cr. The company also approved the allotment of 35 lakh equity shares for ₹42.70 Cr via warrant conversion, increasing paid-up capital and marginally boosting promoter holding. Mr. Ajay Virmani was re-appointed as Managing Director.

📉 Lords Chloro Alkali Delivers Strong Q3 Performance Driven by Revenue Growth and Capital Infusion

Lords Chloro Alkali Limited has announced a significant uplift in its financial performance for the third quarter and nine months ended December 31, 2025. The company's strategic moves and operational efficiency are reflected in the robust year-on-year (YoY) growth across key metrics.

The Numbers:

  • Q3 FY25 Performance:
    • Revenue from operations surged by 45.6% YoY to ₹939.52 Cr.
    • Profit After Tax (PAT) witnessed a remarkable increase of 262.2% YoY, reaching ₹4.61 Cr.
    • Basic Earnings Per Share (EPS) rose to ₹1.83 from ₹0.50 in the corresponding quarter of the previous year.
  • Nine-Month FY25 Performance:
    • Revenue grew substantially by 53.6% YoY to ₹2,924.94 Cr.
    • PAT saw an exceptional increase of 572.9% YoY, totaling ₹24.10 Cr.
    • Basic EPS for the nine-month period stood at ₹9.58.

The Quality & Capital Infusion:

The company's PAT exceeded its Profit Before Tax (PBT) for Q3 FY25 due to substantial tax adjustments, including prior period tax adjustments and deferred tax, which effectively resulted in a net tax credit for the quarter. This, combined with strong operational revenue, bolstered the bottom line.

A key corporate action involved the Board approving the allotment of 35,00,000 equity shares at an issue price of ₹122 per share, aggregating ₹42.70 Cr. This conversion of warrants successfully increased the company's paid-up equity share capital and marginally raised the promoter and promoter group's shareholding to 74.97%.

Management & Governance:

In a move to ensure continuity and strategic direction, the Board approved the re-appointment of Mr. Ajay Virmani as Managing Director for a further term of five years, effective July 12, 2026, subject to shareholder nod. Approvals were also granted for managerial remuneration and the initiation of an Employee Stock Option Plan (ESOP) process.

Risks & Outlook:

The warrant conversion strengthens the company's capital base, which is positive. The re-appointment of the Managing Director provides management stability. Investors will be keen to observe how the company sustains this growth momentum in the coming quarters and manages its expanded capital structure. The reliance on tax adjustments for PAT exceeding PBT in the quarter warrants monitoring for recurrence.

Overall, Lords Chloro Alkali's Q3 FY25 results paint a picture of strong operational performance and strategic financial management, setting a positive tone for the upcoming periods.

Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.